Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shanggan Qingre Oral Liquid for Common Cold (Wind-Heat Syndrome)
CTR20191753Phase 2Completed
- Sponsor
- Xi'an Shangyikang Pharmaceutical Research Institute
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Shanggan Qingre Oral Liquid in upper respiratory infection (URI), nasopharyngitis, sponsored by Xi'an Shangyikang Pharmaceutical Research Institute. Started May 2020; status: completed.
02
Drugs
Shanggan Qingre Oral Liquid
03
Conditions
upper respiratory infection (URI)nasopharyngitis
Beyond the preview
Go deeper on CTR20191753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191753.